Table 1.
Characteristic | Patients (n = 289) | TIM infiltration | P a | ||
---|---|---|---|---|---|
Number | % | Low (n = 145) | High (n = 144) | ||
Age at surgery, yearsb | |||||
Mean ± SD | 63.09 ± 11.06 | 61.68 ± 11.19 | 64.50 ± 10.77 | 0.031 | |
Gender | |||||
Female | 185 | 64.0 | 92 | 93 | 0.84 |
Male | 104 | 36.0 | 53 | 51 | |
pT‐stage | |||||
T2 | 171 | 59.2 | 87 | 84 | 0.81 |
T3 | 85 | 29.4 | 40 | 45 | |
T4 | 33 | 11.4 | 18 | 15 | |
pN‐stage | |||||
N0 | 226 | 78.2 | 113 | 113 | 0.837 |
N1 | 53 | 18.3 | 26 | 27 | |
N2 | 10 | 3.5 | 6 | 4 | |
TNM stage | |||||
II | 159 | 55.0 | 80 | 79 | 0.537 |
III | 79 | 27.3 | 35 | 44 | |
IV | 51 | 17.7 | 30 | 21 | |
Tumor differentiation | |||||
Well, moderate | 154 | 53.3 | 72 | 82 | 0.304 |
Poor | 135 | 46.7 | 73 | 42 | |
Residual tumor | |||||
R0 | 255 | 88.2 | 131 | 124 | 0.266 |
R1 | 34 | 11.8 | 14 | 20 | |
Vascular invasion | |||||
Absent | 196 | 67.8 | 101 | 95 | 0.504 |
Present | 93 | 32.2 | 44 | 49 | |
ACT | |||||
Absent | 179 | 61.9 | 93 | 86 | 0.441 |
Present | 110 | 38.1 | 52 | 58 |
ACT, adjuvant chemotherapy; TIM, tumor‐infiltrating mast cells; SD, standard deviation.
P < 0.05 is considered statistically significant.
The results of continuous variables are presented as mean ± SD.
Bold value is considered statistically significant.